Posted by ABMN Staff on Mar 19th, 2024
I-Mab (NASDAQ:IMAB – Get Free Report) had its price target lowered by research analysts at Needham & Company LLC from $8.00 to $6.00 in a research note issued on Friday, Benzinga reports. The firm presently has a “buy”...
More of this article »